2seventy bio (MEX:TSVT) Beneish M-Score: 0.00 (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TSVT 2seventy bio Inc MEX:TSVT
9 GF Score
Price MXN170.00
View Full Analysis

What is 2seventy bio Beneish M-Score?

2seventy bio MEX:TSVT 9 Beneish M-Score is 0.00 as of Aug. 25, 2026. GuruFocus rates MEX:TSVT with a GF Score™ of 9/100.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for 2seventy bio's Beneish M-Score or its related term are showing as below:

During the past 7 years, the highest Beneish M-Score of 2seventy bio was 0.00. The lowest was 0.00. And the median was 0.00.


2seventy bio Beneish M-Score Historical Data

* Premium members only.

The historical data trend for 2seventy bio's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2seventy bio Beneish M-Score Chart

2seventy bio Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial 0.00 0.00 -2.64 -3.26 -1.78

2seventy bio Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.83 -2.97 -0.19 -1.78 -0.33

MEX:TSVT vs ALMS, TERN, CRVS: Beneish M-Score Comparison

For the Biotechnology subindustry, 2seventy bio's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


2seventy bio Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 2seventy bio's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where 2seventy bio's Beneish M-Score falls into.


MEX:TSVT
9GF Score
2seventy bio Inc MEX:TSVT
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

2seventy bio Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of 2seventy bio for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 3.1144+0.528 * 1.4771+0.404 * 1.1753+0.892 * 0.7908+0.115 * 1.4658
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1075+4.679 * 0.008984-0.327 * 0.9368
=-0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar25) TTM:Last Year (Mar24) TTM:
Total Receivables was MXN489.5 Mil.
Revenue was 469.27 + 61.024 + 266.489 + 164.276 = MXN961.1 Mil.
Gross Profit was 363.849 + -123.403 + 152.915 + 101.017 = MXN494.4 Mil.
Total Current Assets was MXN4,062.6 Mil.
Total Assets was MXN9,820.0 Mil.
Property, Plant and Equipment(Net PPE) was MXN4,748.8 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN131.4 Mil.
Selling, General, & Admin. Expense(SGA) was MXN915.8 Mil.
Total Current Liabilities was MXN846.9 Mil.
Long-Term Debt & Capital Lease Obligation was MXN4,562.2 Mil.
Net Income was 9.861 + -407.103 + -195.584 + 455.786 = MXN-137.0 Mil.
Non Operating Income was 12.766 + 19.646 + 12.799 + 782.415 = MXN827.6 Mil.
Cash Flow from Operations was -224.488 + -197.587 + -206.847 + -423.964 = MXN-1,052.9 Mil.
Total Receivables was MXN198.8 Mil.
Revenue was 206.374 + 181.353 + 209.619 + 618.003 = MXN1,215.3 Mil.
Gross Profit was 131.708 + 127.935 + 123.239 + 540.564 = MXN923.4 Mil.
Total Current Assets was MXN3,532.4 Mil.
Total Assets was MXN8,481.5 Mil.
Property, Plant and Equipment(Net PPE) was MXN4,208.0 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN172.9 Mil.
Selling, General, & Admin. Expense(SGA) was MXN1,045.7 Mil.
Total Current Liabilities was MXN1,002.5 Mil.
Long-Term Debt & Capital Lease Obligation was MXN3,984.3 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(489.524 / 961.059) / (198.773 / 1215.349)
=0.509359 / 0.163552
=3.1144

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(923.446 / 1215.349) / (494.378 / 961.059)
=0.75982 / 0.51441
=1.4771

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4062.63 + 4748.839) / 9820.038) / (1 - (3532.38 + 4207.997) / 8481.533)
=0.102705 / 0.087385
=1.1753

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=961.059 / 1215.349
=0.7908

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(172.879 / (172.879 + 4207.997)) / (131.378 / (131.378 + 4748.839))
=0.039462 / 0.026921
=1.4658

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(915.829 / 961.059) / (1045.724 / 1215.349)
=0.952937 / 0.860431
=1.1075

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4562.22 + 846.908) / 9820.038) / ((3984.28 + 1002.513) / 8481.533)
=0.550826 / 0.587959
=0.9368

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-137.04 - 827.626 - -1052.886) / 9820.038
=0.008984

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

2seventy bio has a M-score of -0.30 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 0.00 mean?
2seventy bio (MEX:TSVT) has a Beneish M-Score of 0.00 as of Aug. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on 2seventy bio and its competitors.
Is 2seventy bio's Beneish M-Score too high?
2seventy bio's current Beneish M-Score is 0.00. Overall, 2seventy bio has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does 2seventy bio's Beneish M-Score compare to ALMS and TERN?
2seventy bio's Beneish M-Score of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on 2seventy bio and its competitors. 2seventy bio's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 2seventy bio stock overvalued right now?
2seventy bio (MEX:TSVT) has a current Beneish M-Score of 0.00. The current Beneish M-Score is 0.00. 2seventy bio's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For 2seventy bio (MEX:TSVT), the current Beneish M-Score is 0.00 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

2seventy bio Business Description

Address 60 Binney Street, Cambridge, MA, USA, 02142
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.
9GF Score

Get the complete analysis for MEX:TSVT

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN170.00
Price